NF1 patients, who carry a deleterious mutation in one allele of the gene encoding the NF1 tumor suppressor, develop benign plexiform neurofibromas when a “second hit” inactivates the remaining functional NF1 gene in a cell within the Schwann cell lineage. Here, NF1 is linked to neoplasm.